The following CORRECTS and REPLACES the release that was issued earlier today: Updated partner for VOC detection platform development

From giving AI the sense of smell and breakthrough in rare disease treatments, Ainos is shaping 2025 with bold technologies and strategic collaborations

Doctorate-level psychologists will provide psychotherapy services, advancing Mentavi Health's mission of making high-quality care available to all via online mental health assessment, diagnosis, and treatment.

The study is one of five clinical efforts - three proof-of-concept investigator-initiated trials (IIT) and two Phase 2 studies - of crofelemer for the rare disease indications of MVID and/or short bowel syndrome with intestinal failure (SBS-IF) in the US, EU, and/or Middle East/North Africa regions; availability of first IIT proof-of-concept results potentially in Q1 2025

Crofelemer, Jaguar's novel plant-based prescription drug, has been granted Orphan-Drug Designation by the FDA and the European Medicines Agency (EMA) for both MVID and SBS-IF

Revolutionizing Pharmacy Benefits: PharmPix and Cost Plus Drugs Partner to Deliver Unprecedented Medication Cost Transparency and Affordability

Black Book unveils its 2025 global survey on mobile electronic health records, showcasing how non-U.S. nations are leveraging innovative platforms to enhance clinician usability, real-time data access, and healthcare delivery across diverse regions.

From giving AI the sense of smell and breakthrough in rare disease treatments, Ainos is shaping 2025 with bold technologies and strategic collaborations

The Naderi Center's website upgrade offers comprehensive procedure insights and booking.

The interview with Dr. John Barr and Jim Patton tackles medication safety and how PillSafe Technologies secures prescriptions, prevents abuse, and protects patients and doctors, leading the fight against the opioid crisis.

Injection Pen Training Video Featuring Unifine SafeControl Safety Pen Needle

As Medical Officer, Dr. Stacy will assist in reviewing addiction and substance-abuse related research and serve as Rehab.com's spokesperson and addiction expert for media and industry partnerships.

The program elevates women dentists beyond the chair by imparting leadership, growth, and success skills for every stage.

World Health Organization (WHO) has classified the global resurgence of cholera at the highest internal level for emergencies; 1.3 to 4 million cholera cases and 21,000 to 143,000 cholera-related deaths occur each year worldwide

Cholera is an acute diarrheal illness caused by infection of the intestine with the bacterium Vibrio cholerae

Crofelemer previously granted orphan-drug designation by the FDA and the European Medicines Agency (EMA) for both short bowel syndrome and microvillus inclusion disease

- GAT Sport®, a trailblazer in sports nutrition, is thrilled to announce Nitraflex® SPORT, is now certified with the Informed Sport programme. Informed Sport certification provides the highest level of quality assurance by testing every batch for substances banned in sport.

Philadelphia expert Dr. Kirk Lozada shares insights about who can benefit from buccal fat removal surgery.

Dr. Nicole Schrader explores the power of combining facelifts with eyelid surgery, fat transfers, and more.

Study Reveals Virtual Cardiac Rehabilitation Outperforms Traditional Methods, Improving Patient Outcomes and Reducing Costs

The 2025 Black Book study is a definitive resource for healthcare organizations navigating the complexities of global EHR procurement. By delivering region-specific evaluations and real-world use cases, it enables IT buyers to make informed decisions tailored to their operational and strategic priorities. Whether seeking global leaders like Epic and Oracle or region-specific champions like Dedalus and MEDITECH, this study provides actionable insights to guide healthcare technology investments.

Experience a new way to enjoy Delicious Nutrition with Just-Add-Water Organic Protein and Collagen peptides shake powders, Available in January 2025

- Xyngari (formerly DMT310) is currently being studied in Phase 3 for the treatment of acne, with topline results from the first Phase 3 STAR-1 study expected in March 2025 -

Hoggan Receives Vital Recredentialing for Microfet Product Line

CFL Foot & Ankle Institute Lake Mary, FL - Innovative Foot & Ankle Mount Dora, FL

Crofelemer is the subject of five clinical efforts - three proof-of-concept investigator-initiated trials (IIT) and two Phase 2 studies - for the rare disease indications of microvillus inclusion disease (MVID) and/or short bowel syndrome with intestinal failure (SBS-IF) in the US, EU, and/or Middle East/North Africa regions; availability of IIT proof-of-concept results potentially in Q2 2025

Virtual event 11:00 AM to 12:00 PM Eastern

The Gaming Kiosks Provide Pediatric Patients With the Opportunity to Experience the Joy of Play During Their Hospital Stay

A Profile of Innovation and Patient-Centered Neurosurgery at Yale Medicine

The Brooklyn-based salon, with locations in Brooklyn Heights and Carroll Gardens, is proud to help women embrace the simple but transformative power of lash extensions, lifts, and tints

Recognizing the connection between sleep disorders and conditions like ADHD, the leader in online mental health testing, diagnosis and care adds a practitioner dedicated to helping people improve the quality of their sleep

CELLEV8 Launches First Post-GLP-1 Gummy Supplement: "SlimCell™" with Clinically Proven Ingredients to Compliment GLP-1

Two of three patients achieved both complete remission and MRD-negative status

High response rates observed in earlier studies continue in ongoing mipletamig trial

Cohort 2 enrollment commencing

GAT Sport®, a trailblazer in sports nutrition, is thrilled to announce the launch of Nitraflex® SPORT. Certified with Informed Sport, safer for athletes and available in three irresistible flavors: Blue Raspberry, Fruit Punch, and Grape Cotton Candy. Nitraflex® SPORT is here to elevate workout experiences for athletes of all levels.

• Exclusive Non-Binding Letter of Intent signed with Target that has more than $40 million in revenue and positive EBITDA in 100% equity consideration transaction

• Acquisition is expected to be TRNR's second transaction within 12 Months

• Advances strategy of using public listing to make accretive acquisitions of profitable and high-growth businesses in the highly fragmented health & wellness market globally

• Target's complementary product and customer footprint Expands TRNR's range of equipment and brands

Electromedical Technologies is excited to share key updates on the WellnessPro Infinity, a revolutionary device redefining the standards of pain management and wellness technology.

Nature’s Answer Continues Its Tradition of Giving: Eighth Year of Fundraising to Support the Community

The 2025 Black Book of Global Healthcare IT user polls reveal a critical need to modernize NHS EHR systems to address the baseline expectations of healthcare professionals and drive meaningful improvements in patient outcomes. Leading systems like Dedalus, Oracle Health, and Nervecentre have set new standards for satisfaction and innovation, offering the NHS valuable insights to elevate its digital health ecosystem and deliver more efficient, patient-centered care.

Individuals with a high polygenic risk are likely to derive the most benefit from lifestyle change and/or therapeutic intervention

As Australia, China, Japan, India and South Korea embrace digital health strategies, supportive policies and growing investments in PHM solutions are driving significant advancements in care coordination, chronic disease management, and health equity across the region.

Bridging functional health with top-tier medical expertise, Kale Health introduces a comprehensive, client-centered approach to modern care.

Integration agreement secured with Beth Israel Deaconess Medical Center, Boston USA